Clinical manifestations and indicators of the hemostasis system in patients with nonalcoholic fatty liver disease with an immune response to SARS-CoV-2

Background. Nonalcoholic fatty liver disease (NAFLD) is often accompanied by comorbid conditions such as obesity, type 2 diabetes, and cardiovascular diseases, which are risk factors for severe coronavirus disease (COVID-19). The latter is characterized by respiratory failure and hyperinflammation w...

Cijeli opis

Bibliografski detalji

Glavni autori:	V.I. Didenko, V.B. Yagmur, I.A. Klenina, O.M. Tatarchuk, K.A. Ruban, O.P. Petishko
Format:	Artigo
Jezik:	Inglês
Izdano:	Zaslavsky O.Yu. 2023-10-01
Serija:	Gastroenterologìa
Teme:	nonalcoholic fatty liver disease sars-cov-2 platelet link of the hemostasis system coagulation factor ii plasminogen activator inhibitor-1
Online pristup:	https://gastro.zaslavsky.com.ua/index.php/journal/article/view/555
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!